12-31FALSE00008841442025Q1P8YP1Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureasur:securityasur:segment00008841442025-01-012025-03-310000884144us-gaap:CommonStockMember2025-01-012025-03-310000884144us-gaap:SeriesAPreferredStockMember2025-01-012025-03-3100008841442025-05-0100008841442025-03-3100008841442024-12-310000884144asur:RecurringMember2025-01-012025-03-310000884144asur:RecurringMember2024-01-012024-03-310000884144asur:ProfessionalServicesRevenueMember2025-01-012025-03-310000884144asur:ProfessionalServicesRevenueMember2024-01-012024-03-3100008841442024-01-012024-03-310000884144us-gaap:CommonStockMember2024-12-310000884144us-gaap:TreasuryStockCommonMember2024-12-310000884144us-gaap:AdditionalPaidInCapitalMember2024-12-310000884144us-gaap:RetainedEarningsMember2024-12-310000884144us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000884144us-gaap:CommonStockMember2025-01-012025-03-310000884144us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310000884144us-gaap:RetainedEarningsMember2025-01-012025-03-310000884144us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310000884144us-gaap:CommonStockMember2025-03-310000884144us-gaap:TreasuryStockCommonMember2025-03-310000884144us-gaap:AdditionalPaidInCapitalMember2025-03-310000884144us-gaap:RetainedEarningsMember2025-03-310000884144us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310000884144us-gaap:CommonStockMember2023-12-310000884144us-gaap:TreasuryStockCommonMember2023-12-310000884144us-gaap:AdditionalPaidInCapitalMember2023-12-310000884144us-gaap:RetainedEarningsMember2023-12-310000884144us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-3100008841442023-12-310000884144us-gaap:CommonStockMember2024-01-012024-03-310000884144us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310000884144us-gaap:TreasuryStockCommonMember2024-01-012024-03-310000884144us-gaap:RetainedEarningsMember2024-01-012024-03-310000884144us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310000884144us-gaap:CommonStockMember2024-03-310000884144us-gaap:TreasuryStockCommonMember2024-03-310000884144us-gaap:AdditionalPaidInCapitalMember2024-03-310000884144us-gaap:RetainedEarningsMember2024-03-310000884144us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-3100008841442024-03-310000884144asur:A2025AcquisitionsMember2025-01-012025-03-310000884144asur:A2025AcquisitionsMember2025-03-310000884144us-gaap:CustomerRelationshipsMemberasur:A2025AcquisitionsMember2025-01-012025-03-310000884144asur:HireclickMember2024-01-012024-12-310000884144asur:HireclickMember2024-07-110000884144asur:HireclickMember2025-03-310000884144asur:HireclickMemberus-gaap:CustomerRelationshipsMember2024-07-110000884144asur:HireclickMemberus-gaap:DevelopedTechnologyRightsMember2024-07-110000884144asur:HireclickMemberus-gaap:CustomerRelationshipsMember2024-01-012024-12-310000884144asur:HireclickMemberus-gaap:DevelopedTechnologyRightsMember2024-01-012024-12-310000884144asur:A2024AcquisitionsMember2024-01-012024-12-310000884144asur:A2024AcquisitionsMember2025-01-012025-03-310000884144asur:A2024AcquisitionsMember2025-03-310000884144srt:MinimumMemberasur:A2024AcquisitionsMember2025-03-310000884144srt:MaximumMemberasur:A2024AcquisitionsMember2025-03-310000884144us-gaap:CustomerRelationshipsMemberasur:A2024AcquisitionsMember2025-01-012025-03-310000884144us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310000884144us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-03-310000884144us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-03-310000884144us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-03-310000884144us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2025-03-310000884144us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-03-310000884144us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-03-310000884144us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-03-310000884144us-gaap:FairValueMeasurementsRecurringMember2025-03-310000884144us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2025-03-310000884144us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2025-03-310000884144us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2025-03-310000884144us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000884144us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-12-310000884144us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-12-310000884144us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-12-310000884144us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310000884144us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-12-310000884144us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-12-310000884144us-gaap:AvailableforsaleSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-12-310000884144us-gaap:FairValueMeasurementsRecurringMember2024-12-310000884144us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2024-12-310000884144us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-12-310000884144us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2024-12-310000884144us-gaap:CorporateDebtSecuritiesMember2025-03-310000884144us-gaap:MunicipalBondsMember2025-03-310000884144us-gaap:USGovernmentAgenciesDebtSecuritiesMember2025-03-310000884144us-gaap:AvailableforsaleSecuritiesMember2025-03-310000884144us-gaap:CorporateDebtSecuritiesMember2024-12-310000884144us-gaap:MunicipalBondsMember2024-12-310000884144us-gaap:USGovernmentAgenciesDebtSecuritiesMember2024-12-310000884144us-gaap:AvailableforsaleSecuritiesMember2024-12-310000884144asur:IndividuallyMember2025-03-310000884144asur:IndividuallyMember2024-12-310000884144asur:AggregateMember2024-12-310000884144us-gaap:CustomerRelationshipsMember2024-12-310000884144us-gaap:CustomerRelationshipsMember2025-01-012025-03-310000884144us-gaap:CustomerRelationshipsMember2025-03-310000884144us-gaap:DevelopedTechnologyRightsMember2024-12-310000884144us-gaap:DevelopedTechnologyRightsMember2025-01-012025-03-310000884144us-gaap:DevelopedTechnologyRightsMember2025-03-310000884144us-gaap:TradeNamesMember2024-12-310000884144us-gaap:TradeNamesMember2025-01-012025-03-310000884144us-gaap:TradeNamesMember2025-03-310000884144us-gaap:NoncompeteAgreementsMember2024-12-310000884144us-gaap:NoncompeteAgreementsMember2025-01-012025-03-310000884144us-gaap:NoncompeteAgreementsMember2025-03-3100008841442024-01-012024-12-310000884144asur:NotesPayableAcquisitionsMember2025-01-012025-03-310000884144srt:MinimumMemberasur:NotesPayableAcquisitionsMember2025-03-310000884144srt:MaximumMemberasur:NotesPayableAcquisitionsMember2025-03-310000884144asur:NotesPayableAcquisitionsMember2025-03-310000884144asur:NotesPayableAcquisitionsMember2024-12-310000884144us-gaap:NotesPayableOtherPayablesMember2025-01-012025-03-310000884144us-gaap:NotesPayableOtherPayablesMember2025-03-310000884144us-gaap:NotesPayableOtherPayablesMember2024-12-3100008841442025-04-012025-03-310000884144srt:MinimumMember2025-03-310000884144srt:MaximumMember2025-03-310000884144asur:A2018PlanMember2025-03-310000884144us-gaap:PerformanceSharesMember2025-01-012025-03-310000884144us-gaap:PerformanceSharesMember2024-01-012024-03-310000884144srt:MinimumMemberasur:A2024PSUMember2024-01-010000884144srt:MaximumMemberasur:A2024PSUMember2024-01-010000884144asur:A2024PSUMember2025-03-060000884144srt:MinimumMemberasur:A2025PSUMember2025-01-010000884144srt:MaximumMemberasur:A2025PSUMember2025-01-010000884144us-gaap:OperatingSegmentsMemberasur:ReportableSegmentMember2025-01-012025-03-310000884144us-gaap:OperatingSegmentsMemberasur:ReportableSegmentMember2024-01-012024-03-310000884144us-gaap:SubsequentEventMember2025-04-100000884144us-gaap:SubsequentEventMember2025-04-012025-05-01
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
|
|
|
|
|
|
☒ |
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended March 31, 2025 |
|
|
|
|
|
|
☐ |
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from __ to __ |
|
|
|
Commission File Number: 1-34522 |
ASURE SOFTWARE, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware |
|
|
|
74-2415696 |
(State or other jurisdiction of incorporation) |
|
|
|
(I.R.S. Employer Identification No.) |
|
|
|
|
|
405 Colorado Street, Suite 1800, Austin, Texas |
|
|
|
78701 |
(Address of principal executive offices) |
|
|
|
(Zip Code) |
|
|
|
512-437-2700 |
(Registrant’s Telephone Number, including Area Code) |
None |
(Former name, former address and former fiscal year, if changed since last report) |
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, $0.01 par value |
|
ASUR |
|
The Nasdaq Capital Market |
Series A Junior Participating Preferred Share Purchase Rights |
|
|
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. |
|
|
☒ |
Yes |
☐ |
No |
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). |
|
|
☒ |
Yes |
☐ |
No |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. |
|
Large accelerated filer |
☐ |
|
Accelerated filer |
☒ |
|
Non-accelerated filer |
☐ |
|
Smaller reporting company |
☒ |
|
|
|
|
Emerging growth company |
☐ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |
|
|
☐ |
|
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). |
|
|
|
|
|
☐ |
Yes |
☒ |
No |
As of April 30, 2024, 27,154,007 shares of the registrant’s Common Stock, $0.01 par value, were outstanding.
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
Page |
|
Item 1. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 2. |
|
|
Item 3. |
|
|
Item 4. |
|
|
|
|
|
|
|
|
|
Item 1. |
|
|
Item 1A. |
|
|
Item 2. |
|
|
Item 3. |
|
|
Item 4. |
|
|
Item 5. |
|
|
Item 6. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PART I
ITEM 1. FINANCIAL STATEMENTS
ASURE SOFTWARE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
December 31, 2024 |
ASSETS |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
14,076 |
|
|
$ |
21,425 |
|
Accounts receivable, net of allowance for credit losses of $6,545 and $6,328 at March 31, 2025 and December 31, 2024, respectively |
15,800 |
|
|
18,154 |
|
Inventory |
220 |
|
|
195 |
|
Prepaid expenses and other current assets |
5,970 |
|
|
4,888 |
|
Total current assets before funds held for clients |
36,066 |
|
|
44,662 |
|
Funds held for clients |
257,019 |
|
|
192,615 |
|
Total current assets |
293,085 |
|
|
237,277 |
|
Property and equipment, net |
20,999 |
|
|
19,669 |
|
Goodwill |
94,724 |
|
|
94,724 |
|
Intangible assets, net |
73,003 |
|
|
69,114 |
|
Operating lease assets, net |
4,403 |
|
|
4,041 |
|
Other assets, net |
12,727 |
|
|
11,813 |
|
Total assets |
$ |
498,941 |
|
|
$ |
436,638 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
Current liabilities: |
|
|
|
Current portion of notes payable |
$ |
7,948 |
|
|
$ |
7,008 |
|
Accounts payable |
2,475 |
|
|
1,364 |
|
Accrued compensation and benefits |
2,911 |
|
|
4,485 |
|
Operating lease liabilities, current |
1,432 |
|
|
1,438 |
|
Other accrued liabilities |
6,071 |
|
|
6,600 |
|
Deferred revenue |
4,662 |
|
|
8,363 |
|
Total current liabilities before client fund obligations |
25,499 |
|
|
29,258 |
|
Client fund obligations |
258,586 |
|
|
194,378 |
|
Total current liabilities |
284,085 |
|
|
223,636 |
|
Long-term liabilities: |
|
|
|
Deferred revenue |
3,321 |
|
|
3,430 |
|
Deferred tax liability |
2,903 |
|
|
2,612 |
|
Notes payable, net of current portion |
6,172 |
|
|
5,709 |
|
Operating lease liabilities, noncurrent |
3,892 |
|
|
3,578 |
|
Other liabilities |
905 |
|
|
358 |
|
Total long-term liabilities |
17,193 |
|
|
15,687 |
|
Total liabilities |
301,278 |
|
|
239,323 |
|
Commitments and contingencies - Note 8 |
|
|
|
Stockholders’ equity: |
|
|
|
Preferred stock, $0.01 par value; 1,500 shares authorized; none issued or outstanding |
— |
|
|
— |
|
Common stock, $0.01 par value; 44,000 shares authorized; 27,122 and 26,671 shares issued, 27,122 and 26,671 shares outstanding at March 31, 2025 and December 31, 2024, respectively |
271 |
|
|
267 |
|
Treasury stock at cost, zero(1) shares at March 31, 2025 and December 31, 2024 |
— |
|
|
— |
|
Additional paid-in capital |
507,149 |
|
|
504,849 |
|
Accumulated deficit |
(309,624) |
|
|
(307,226) |
|
Accumulated other comprehensive loss |
(133) |
|
|
(575) |
|
Total stockholders’ equity |
197,663 |
|
|
197,315 |
|
Total liabilities and stockholders’ equity |
$ |
498,941 |
|
|
$ |
436,638 |
|
(1) The aggregate Treasury stock of prior repurchases of our own common stock was retired and subsequently issued effective January 1, 2024. See the Condensed Consolidated Statement of Changes in Stockholders' Equity for the impact of this transaction. |
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
ASURE SOFTWARE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(in thousands, except per share amounts)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
2025 |
|
2024 |
Revenue: |
|
|
|
|
|
|
Recurring |
|
|
|
$ |
33,187 |
|
|
$ |
30,273 |
|
Professional services, hardware and other |
|
|
|
1,667 |
|
|
1,379 |
|
Total revenue |
|
|
|
34,854 |
|
|
31,652 |
|
Cost of Sales |
|
|
|
10,246 |
|
|
9,045 |
|
Gross profit |
|
|
|
24,608 |
|
|
22,607 |
|
Operating expenses: |
|
|
|
|
|
|
Sales and marketing |
|
|
|
8,386 |
|
|
7,767 |
|
General and administrative |
|
|
|
11,900 |
|
|
10,063 |
|
Research and development |
|
|
|
2,029 |
|
|
1,769 |
|
Amortization of intangible assets |
|
|
|
4,308 |
|
|
3,449 |
|
Total operating expenses |
|
|
|
26,623 |
|
|
23,048 |
|
Loss from operations |
|
|
|
(2,015) |
|
|
(441) |
|
Interest income |
|
|
|
171 |
|
|
336 |
|
Interest expense |
|
|
|
(451) |
|
|
(180) |
|
Other income, net |
|
|
|
188 |
|
|
10 |
|
Loss from operations before income taxes |
|
|
|
(2,107) |
|
|
(275) |
|
Income tax expense |
|
|
|
291 |
|
|
33 |
|
Net loss |
|
|
|
(2,398) |
|
|
(308) |
|
Other comprehensive income (loss): |
|
|
|
|
|
|
Unrealized income (loss) on marketable securities |
|
|
|
442 |
|
|
(244) |
|
Comprehensive loss |
|
|
|
$ |
(1,956) |
|
|
$ |
(552) |
|
|
|
|
|
|
|
|
Basic and diluted loss per share |
|
|
|
|
|
|
Basic |
|
|
|
$ |
(0.09) |
|
|
$ |
(0.01) |
|
Diluted |
|
|
|
$ |
(0.09) |
|
|
$ |
(0.01) |
|
|
|
|
|
|
|
|
Weighted average basic and diluted shares |
|
|
|
|
|
|
Basic |
|
|
|
26,961 |
|
|
25,334 |
|
Diluted |
|
|
|
26,961 |
|
|
25,334 |
|
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
ASURE SOFTWARE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(in thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock Outstanding |
|
Common Stock Amount |
|
Treasury Stock |
|
Additional Paid-in Capital |
|
Accumulated Deficit |
|
Other Comprehensive Loss |
|
Total Stockholders’ Equity |
Balance at December 31, 2024 |
26,671 |
|
|
$ |
267 |
|
|
$ |
— |
|
|
$ |
504,849 |
|
|
$ |
(307,226) |
|
|
$ |
(575) |
|
|
$ |
197,315 |
|
Stock issued upon option exercise and vesting of restricted and performance stock units |
451 |
|
|
4 |
|
|
— |
|
|
437 |
|
|
— |
|
|
— |
|
|
441 |
|
Share based compensation |
— |
|
|
— |
|
|
— |
|
|
1,863 |
|
|
— |
|
|
— |
|
|
1,863 |
|
Net loss |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(2,398) |
|
|
— |
|
|
(2,398) |
|
Other comprehensive loss |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
442 |
|
|
442 |
|
Balance at March 31, 2025 |
27,122 |
|
|
$ |
271 |
|
|
$ |
— |
|
|
$ |
507,149 |
|
|
$ |
(309,624) |
|
|
$ |
(133) |
|
|
$ |
197,663 |
|
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
ASURE SOFTWARE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(in thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock Outstanding |
|
Common Stock Amount |
|
Treasury Stock |
|
Additional Paid-in Capital |
|
Accumulated Deficit |
|
Other Comprehensive Loss |
|
Total Stockholders’ Equity |
Balance at December 31, 2023 |
24,998 |
|
|
$ |
254 |
|
|
$ |
(5,017) |
|
|
$ |
487,973 |
|
|
$ |
(290,440) |
|
|
$ |
(1,115) |
|
|
$ |
191,655 |
|
Stock issued upon option exercise and vesting of restricted stock units |
301 |
|
|
3 |
|
|
— |
|
|
173 |
|
|
— |
|
|
— |
|
|
176 |
|
Stock issued for acquisitions |
450 |
|
|
5 |
|
|
— |
|
|
4,489 |
|
|
— |
|
|
— |
|
|
4,494 |
|
Share based compensation |
— |
|
|
— |
|
|
— |
|
|
1,902 |
|
|
— |
|
|
— |
|
|
1,902 |
|
Retirement and reissuance of treasury shares |
— |
|
|
(4) |
|
|
5,017 |
|
|
— |
|
|
(5,013) |
|
|
— |
|
|
— |
|
Net income |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(308) |
|
|
— |
|
|
(308) |
|
Other comprehensive income |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(244) |
|
|
(244) |
|
Balance at March 31, 2024 |
25,749 |
|
|
$ |
258 |
|
|
$ |
— |
|
|
$ |
494,537 |
|
|
$ |
(295,761) |
|
|
$ |
(1,359) |
|
|
$ |
197,675 |
|
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
ASURE SOFTWARE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
2025 |
|
2024 |
Cash flows from operating activities: |
|
|
|
Net loss |
$ |
(2,398) |
|
|
$ |
(308) |
|
Adjustments to reconcile loss to net cash provided by (used in) operations: |
|
|
|
Depreciation and amortization |
5,972 |
|
|
4,860 |
|
Amortization of operating lease assets |
374 |
|
|
335 |
|
Amortization of debt financing costs and discount |
253 |
|
|
142 |
|
Non-cash interest expense |
197 |
|
|
— |
|
Net accretion of discounts on available-for-sale securities |
(110) |
|
|
(78) |
|
Provision for expected losses |
93 |
|
|
46 |
|
Provision for deferred income taxes |
291 |
|
|
24 |
|
Net realized gains on sales of available-for-sale securities |
(656) |
|
|
(652) |
|
Share-based compensation |
1,863 |
|
|
1,902 |
|
Changes in operating assets and liabilities: |
|
|
|
Accounts receivable |
2,261 |
|
|
(919) |
|
Inventory |
(24) |
|
|
(50) |
|
Prepaid expenses and other assets |
(1,049) |
|
|
(473) |
|
Operating lease right-of-use assets |
— |
|
|
30 |
|
Accounts payable |
903 |
|
|
(960) |
|
Accrued expenses and other long-term obligations |
(1,737) |
|
|
(2,665) |
|
Operating lease liabilities |
(427) |
|
|
(141) |
|
Deferred revenue |
(3,810) |
|
|
(5,040) |
|
Net cash provided by (used in) operating activities |
1,996 |
|
|
(3,947) |
|
Cash flows from investing activities: |
|
|
|
Acquisition of intangible asset |
(6,346) |
|
|
(710) |
|
Purchases of property and equipment |
(192) |
|
|
(240) |
|
Software capitalization costs |
(2,769) |
|
|
(2,435) |
|
Purchases of available-for-sale securities |
(6,589) |
|
|
(3,516) |
|
Proceeds from sales and maturities of available-for-sale securities |
3,266 |
|
|
2,406 |
|
Net cash used in investing activities |
(12,630) |
|
|
(4,495) |
|
Cash flows from financing activities: |
|
|
|
Payments made on amounts due for the acquisition of intangible assets |
(723) |
|
|
(236) |
|
Net proceeds from issuance of common stock |
441 |
|
|
176 |
|
Net change in client fund obligations |
64,207 |
|
|
21,122 |
|
Net cash provided by financing activities |
63,925 |
|
|
21,062 |
|
Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents |
53,291 |
|
|
12,620 |
|
Cash and cash equivalents, beginning of period |
145,712 |
|
|
177,622 |
|
Cash and cash equivalents, end of period |
$ |
199,003 |
|
|
$ |
190,242 |
|
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
ASURE SOFTWARE, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
(in thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
2025 |
|
2024 |
Reconciliation of cash, cash equivalents, and restricted cash, and restricted cash equivalents to the Condensed Consolidated Balance Sheets |
Cash and cash equivalents |
$ |
14,076 |
|
|
$ |
23,166 |
|
Restricted cash and restricted cash equivalents included in funds held for clients |
184,927 |
|
|
167,076 |
|
Total cash, cash equivalents, restricted cash, and restricted cash equivalents |
$ |
199,003 |
|
|
$ |
190,242 |
|
|
|
|
|
Supplemental information: |
|
|
|
Cash paid for interest |
$ |
125 |
|
|
$ |
— |
|
|
|
|
|
Non-cash investing and financing activities: |
|
|
|
Acquisition of intangible assets |
$ |
750 |
|
|
$ |
6,345 |
|
Notes payable issued for acquisitions |
$ |
1,150 |
|
|
$ |
827 |
|
Shares issued for acquisitions |
$ |
— |
|
|
$ |
4,494 |
|
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
ASURE SOFTWARE, INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Amounts in thousands, except per share data unless otherwise noted)
NOTE 1 - THE COMPANY AND BASIS OF PRESENTATION
Asure Software, Inc. (“Asure”, the “Company”, “we” and “our”), a Delaware corporation, is a provider of cloud-based Human Capital Management (“HCM”) software solutions delivered as Software-as-a-Service (“SaaS”) to businesses of all sizes. We offer human resources (“HR”) tools necessary to build a thriving workforce, provide the resources to stay compliant with dynamic federal, state, and local tax jurisdictions and their respective labor laws, freeing cash flows so these businesses can spend their financial capital on growing their businesses rather than administrative overhead that can impede growth. Our solutions also provide new ways for employers to connect with their employees and strengthen relationships with their talent. At the core of our offering is the Asure HCM platform—a SaaS-based system that includes Payroll & Tax filing, Recruiting, Time & Attendance software, HR management tools, and Benefits Administration. This platform serves as the foundation for delivering both our core software and a range of complementary, technology-enabled services. These include AsureMarketplace™, which automates data exchange between our HCM system and third-party providers to increase efficiency, accuracy, and breadth of services. Our HR Compliance services combine expert guidance with scalable digital delivery. AsurePay™, our Visa-branded payroll card, provides employees with fast, secure access to earned wages. Additionally, through our licensed brokerage, we offer Insurance Services that help employers manage benefits and reduce administrative costs. We deliver our solutions directly and through a national network of Reseller Partners.
We strive to be the most trusted HCM resource. Our solutions solve three primary challenges that prevent businesses from growing: HR complexity, allocation of human and financial capital, and the ability to build great teams. We sell our solutions through both direct and partner channels. We supplement our direct sales efforts with partner programs that afford us access to opportunities in various geographic and industry niches. Asure has two types of partners: Reseller Partners that white label our products while providing value-added services to their clients (our indirect clients) and Referral Partners that provide us with client leads but do not resell our solutions. We have and will continue to invest in research and development to expand our solutions. Our solutions reduce the administrative burden on employers and increase employee productivity while managing the employment lifecycle. The Asure HCM suite includes eight product lines: Asure Payroll & Tax, Asure Tax Management Solutions, AsureRecruiting™, Asure Time & Attendance, Asure HR Compliance, Asure Insurance and Benefits Administration, AsureMarketplace™, and AsurePay™.
We develop, market, sell and support our offerings nationwide through our principal office in Austin, Texas, and from our other office locations in Alabama, California, Florida, New Jersey, New York, North Carolina, Ohio, South Dakota, Tennessee, and Vermont.
We have prepared the accompanying unaudited Condensed Consolidated Financial Statements in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and accordingly, they do not include all information and footnotes required under U.S. generally accepted accounting principles (“U.S. GAAP”) for complete financial statements.
In the opinion of management, these interim financial statements contain all adjustments, consisting of normal, recurring adjustments, necessary for a fair presentation of our financial position as of March 31, 2025, comprehensive (loss) income and changes in stockholders’ equity for the three months ended March 31, 2025 and March 31, 2024, and cash flows for the three months ended March 31, 2025 and March 31, 2024.
These unaudited Condensed Consolidated Financial Statements should be read in conjunction with our audited Consolidated Financial Statements and notes thereto filed with the SEC in our annual report on Form 10-K for the fiscal year ended December 31, 2024 (our “2024 Annual Report on Form 10-K”). Our results for any interim period are not necessarily indicative of results for a full fiscal year.
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES
REPORTABLE SEGMENTS
Our chief operating decision maker is our Chairman and Chief Executive Officer, Patrick Goepel, who reviews financial information presented on a company-wide basis. Thus, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 280, we determined that we have a single reportable segment that primarily derives our revenue in the United States by providing payroll services to customers.
USE OF ESTIMATES
Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of the assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. These estimates are subjective in nature and involve judgments. The more significant estimates made by management include the valuation allowance for the gross deferred tax assets, the determination of the fair value of our long-lived assets, and the fair value of assets acquired, and liabilities assumed during acquisitions. We base our estimates on historical experience and on various other assumptions management believes reasonable under the given circumstances. These estimates could be materially different under different conditions and assumptions.
CASH AND CASH EQUIVALENTS
We consider all highly liquid investments with maturity of 90 days or less to be cash equivalents. Cash equivalents include investments in an institutional money market fund, which invests in U.S. Treasury bills, notes and bonds, and/or repurchase agreements, backed by such obligations. Carrying value approximates fair value.
RECENT ACCOUNTING PRONOUNCEMENTS
In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (Topic 740), which requires companies to disaggregate information about their effective tax rate reconciliation as well as information on income taxes paid. The standard applies to all entities subject to income taxes. The standard becomes effective for public entities for annual periods beginning after December 15, 2024. We are currently evaluating this standard and the potential effects of these changes to our consolidated financial statements and have adopted this new standard for the current fiscal year. We do not expect it will have a material impact.
ACCUMULATED OTHER COMPREHENSIVE LOSS
As of March 31, 2025 and December 31, 2024, accumulated other comprehensive loss consisted of net unrealized gains and losses on available-for-sale securities.
NOTE 3 - BUSINESS COMBINATIONS AND ASSET ACQUISITIONS
2025
Asset Acquisitions
During the three months ended March 31, 2025, we completed three customer relationship asset acquisitions. The total purchase price of these acquisitions was $7,705, which consisted of $6,362 of cash paid during the three months ended March 31, 2025, $193 of cash to be paid over the next 12 months, and the delivery of promissory notes in the amount of $1,150, net of discounts. The acquired customer relationships are recorded as intangible assets and are being amortized on a straight-line basis over eight years. As of March 31, 2025, the outstanding principal balance of the promissory notes for these acquisitions was $1,402.
2024
Business Combinations
Effective July 11, 2024, we purchased substantially all the assets of an applicant tracking technology company based out of South Dakota for an innovative hiring solution designed to streamline the recruitment process for small and mid-sized businesses. This strategic acquisition reinforces Asure’s commitment to delivering comprehensive, user-friendly tools that simplify people management. The aggregate purchase price paid for the business was $15,162, consisting of $7,900 paid in cash on hand, $3,000 in the form of a promissory note ($1,716 net of discount), and 525 shares of Asure common stock, which had a fair value of $4,262 on the day of acquisition. As of March 31, 2025, the promissory note had an outstanding principal balance of $3,000 and matures on July 1, 2029.
The purchase consideration was allocated among the acquired assets, which consist of a customer relationships intangible asset with fair value of $2,700, and a developed technology intangible asset with a fair value of $3,200. Additionally, we assumed $237 of deferred revenue and $498 of other accrued liabilities as part of the transaction. The intangible assets are being amortized on a straight-line basis over eight and five years, respectively.
The remaining $8,713 of excess purchase consideration was allocated to goodwill, which is generally expected to be deductible for tax purposes. This represents the knowledge and experience of the employees retained as part of the transaction as well as the synergies and economies of scale expected from expanding the Midwest operating region to a national scale.
Asset Acquisitions
During the year ended December 31, 2024, we completed eleven customer relationship asset acquisitions. The total purchase price of these acquisitions was $14,607, which consisted of $5,842 of cash paid during the year ended December 31, 2024, $723 of cash paid during the three months ended March 31, 2025, $1,198 of cash to be paid over the next 12 months, $595 of cash to be paid thereafter, the delivery of promissory notes in the amount of $1,386, net of discounts, and the delivery of 500 shares of Asure common stock, which had an aggregate fair value of $4,863 at the acquisition dates. The purchase price for certain acquisitions is subject to adjustments for contingent events to be resolved primarily over the next one to three years, including revenue generated from the acquired assets. The acquired customer relationships are recorded as intangible assets and are being amortized on a straight-line basis over eight years. As of March 31, 2025, the outstanding principal balance of the promissory notes for these acquisitions was $1,663.
NOTE 4 - INVESTMENTS AND FAIR VALUE MEASUREMENTS
Accounting Standards Codification (ASC) 820 “Fair Value Measurement” (ASC 820) defines fair value, establishes a framework for measuring fair value under U.S. GAAP and enhances disclosures about fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. ASC 820 describes a fair value hierarchy based on the following three levels of inputs that may be used to measure fair value, of which the first two are considered observable and the last unobservable:
|
|
|
|
|
|
|
|
|
Level 1: |
|
Quoted prices in active markets for identical assets or liabilities; |
|
|
|
Level 2: |
|
Quoted prices in active markets for similar assets or liabilities; quoted prices in markets that are not active for identical or similar assets or liabilities; and model-driven valuations whose significant inputs are observable; and |
|
|
|
Level 3: |
|
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. |
The following table presents the fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis for the periods presented below (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Carrying Value |
|
Level 1 |
|
Level 2 |
|
Level 3 |
March 31, 2025 |
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
Funds held for clients |
|
|
|
|
|
|
|
Money market funds |
$ |
4,788 |
|
|
$ |
4,788 |
|
|
$ |
— |
|
|
$ |
— |
|
Available-for-sale securities |
72,092 |
|
|
— |
|
|
72,092 |
|
|
— |
|
Total |
$ |
76,880 |
|
|
$ |
4,788 |
|
|
$ |
72,092 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
December 31, 2024 |
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
Funds held for clients |
|
|
|
|
|
|
|
Money market funds |
$ |
8,105 |
|
|
$ |
8,105 |
|
|
$ |
— |
|
|
$ |
— |
|
Available-for-sale securities |
68,328 |
|
|
— |
|
|
68,328 |
|
|
— |
|
Total |
$ |
76,433 |
|
|
$ |
8,105 |
|
|
$ |
68,328 |
|
|
$ |
— |
|
Cash equivalents and investments classified as available-for-sale within funds held for clients consisted of the following for the periods presented below (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortized Cost |
|
Gross
Unrealized
Gains (1)
|
|
Gross
Unrealized
Losses (1)
|
|
Aggregate Estimated Fair Value |
March 31, 2025 |
|
|
|
|
|
|
|
Cash equivalents |
$ |
4,789 |
|
|
$ |
— |
|
|
$ |
(1) |
|
|
$ |
4,788 |
|
Available-for-sale securities: |
|
|
|
|
|
|
|
Corporate debt securities |
66,579 |
|
|
305 |
|
|
(364) |
|
|
66,520 |
|
Municipal bonds |
3,191 |
|
|
— |
|
|
(76) |
|
|
3,115 |
|
U.S. Government agency securities |
2,454 |
|
|
13 |
|
|
(10) |
|
|
2,457 |
|
Total available-for-sale securities |
72,224 |
|
|
318 |
|
|
(450) |
|
|
72,092 |
|
|
|
|
|
|
|
|
|
Total(2) |
$ |
77,013 |
|
|
$ |
318 |
|
|
$ |
(451) |
|
|
$ |
76,880 |
|
|
|
|
|
|
|
|
|
December 31, 2024 |
|
|
|
|
|
|
|
Cash equivalents |
$ |
8,115 |
|
|
$ |
— |
|
|
$ |
(10) |
|
|
$ |
8,105 |
|
Available-for-sale securities: |
|
|
|
|
|
|
|
Corporate debt securities |
63,253 |
|
|
164 |
|
|
(619) |
|
|
62,798 |
|
Municipal bonds |
3,194 |
|
|
— |
|
|
(104) |
|
|
3,090 |
|
U.S. Government agency securities |
2,449 |
|
|
6 |
|
|
(15) |
|
|
2,440 |
|
Total available-for-sale securities |
68,896 |
|
|
170 |
|
|
(738) |
|
|
68,328 |
|
|
|
|
|
|
|
|
|
Total(2) |
$ |
77,011 |
|
|
$ |
170 |
|
|
$ |
(748) |
|
|
$ |
76,433 |
|
(1)Unrealized gains and losses on available-for-sale securities are included as a component of comprehensive loss. As of March 31, 2025 and December 31, 2024, there were 79 and 45 securities, respectively, in an unrealized gain position and there were 61 and 89 securities in an unrealized loss position, respectively. As of March 31, 2025, these unrealized losses were less than $29 individually and $450 in the aggregate. As of December 31, 2024, these unrealized losses were less than $38 individually and $738 in the aggregate. We invest in high quality securities with roughly 67% of our portfolio made up of A ratings and above with unrealized losses primarily attributable to macroeconomic factors rather than credit related. We have no material individual securities that have been in a continuous unrealized loss position greater than twelve months. We do not intend to sell these investments, and we do not expect to sell these investments before recovery of their amortized cost basis, which may be at maturity. We review our investments to identify and evaluate investments that indicate possible credit losses. Factors considered in determining whether a loss is a credit loss include the length of time and extent to which fair value has been less than the cost basis, the financial condition and near-term prospects of the investee, and our intent and ability to hold the investment for a period of time sufficient to allow for any anticipated recovery in market value.
(2)At March 31, 2025 and December 31, 2024, none of these securities were classified as cash and cash equivalents on the accompanying Condensed Consolidated Balance Sheets.
Funds held for clients represent assets that we have classified for use solely for the purposes of satisfying the obligations to remit funds relating to our payroll and payroll tax filing services, which are classified as client funds obligations on our Condensed Consolidated Balance Sheets.
Funds held for clients have been invested in the following categories for the periods presented below (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
December 31, 2024 |
Restricted cash and cash equivalents held to satisfy client funds obligations |
$ |
184,927 |
|
|
$ |
124,287 |
|
Restricted short-term marketable securities held to satisfy client funds obligations |
9,903 |
|
|
5,273 |
|
Restricted long-term marketable securities held to satisfy client funds obligations |
62,189 |
|
|
63,055 |
|
Total funds held for clients |
$ |
257,019 |
|
|
$ |
192,615 |
|
Expected maturities of available-for-sale securities are as of March 31, 2025, are as follows (in thousands):
|
|
|
|
|
|
One year or less |
$ |
9,903 |
|
After one year through five years |
62,189 |
|
Total |
$ |
72,092 |
|
NOTE 5 - GOODWILL AND OTHER INTANGIBLE ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2024 |
|
Acquisitions |
|
March 31, 2025 |
Goodwill |
$ |
94,724 |
|
|
$ |
— |
|
|
$ |
94,724 |
|
We believe significant synergies are expected to arise from our strategic acquisitions and their assembled work forces. This factor contributed to a purchase price that was in excess of the fair value of the net assets acquired and, as a result, we recorded goodwill for each acquisition. A portion of acquired goodwill will be amortizable for tax purposes. As of March 31, 2025, there has been no impairment of goodwill based on the qualitative assessments we have performed.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Intangible Assets |
December 31, 2024 |
|
Acquisitions |
|
March 31, 2025 |
Customer relationships |
$ |
148,097 |
|
|
$ |
8,247 |
|
|
$ |
156,344 |
|
Developed technology |
15,201 |
|
— |
|
|
15,201 |
Trade names |
880 |
|
— |
|
|
880 |
Non-compete agreements |
1,032 |
|
— |
|
|
1,032 |
Total |
$ |
165,210 |
|
|
$ |
8,247 |
|
|
$ |
173,457 |
|
The gross carrying amount and accumulated amortization of our intangible assets are as follows for the periods presented below (in thousands, except weighted average periods):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average Amortization Period (in Years) |
|
Gross |
|
Accumulated Amortization |
|
Net |
March 31, 2025 |
|
|
|
|
|
|
|
|
Customer relationships |
|
8.5 |
|
$ |
156,344 |
|
|
$ |
(87,218) |
|
|
$ |
69,126 |
|
Developed technology |
|
6.5 |
|
15,201 |
|
|
(11,411) |
|
|
3,790 |
|
Trade names |
|
4.3 |
|
880 |
|
|
(880) |
|
|
— |
|
Non-compete agreements |
|
5.2 |
|
1,032 |
|
|
(945) |
|
|
87 |
|
|
|
8.3 |
|
$ |
173,457 |
|
|
$ |
(100,454) |
|
|
$ |
73,003 |
|
|
|
|
|
|
|
|
|
|
December 31, 2024 |
|
|
|
|
|
|
|
|
Customer relationships |
|
8.6 |
|
$ |
148,097 |
|
|
$ |
(83,074) |
|
|
$ |
65,023 |
|
Developed technology |
|
6.5 |
|
15,201 |
|
|
(11,201) |
|
|
4,000 |
|
Trade names |
|
4.3 |
|
880 |
|
|
(880) |
|
|
— |
|
Non-compete agreements |
|
5.2 |
|
1,032 |
|
|
(941) |
|
|
91 |
|
|
|
8.3 |
|
$ |
165,210 |
|
|
$ |
(96,096) |
|
|
$ |
69,114 |
|
We record amortization expenses using the straight-line method over the estimated useful lives of the intangible assets, as noted above. Amortization expenses recorded in Operating Expenses were $4,308 and $3,449 for the three months ended March 31, 2025 and 2024, respectively. Amortization expenses recorded in Cost of Sales were $50 for the three months ended March 31, 2025 and 2024. There was no impairment of intangibles during the three months ended March 31, 2025 based on the qualitative assessment we performed. However, if market, political and other conditions over which we have no control continue to affect the capital markets and our stock price declines, we may experience an impairment of our intangibles in future quarters.
The following table summarizes the future estimated amortization expense relating to our intangible assets for the period presented below (in thousands):
|
|
|
|
|
|
2025 (Remaining) |
$ |
13,419 |
|
2026 |
14,833 |
|
2027 |
12,638 |
|
2028 |
11,193 |
|
2029 |
9,030 |
|
2030 |
5,399 |
|
Thereafter |
6,491 |
|
|
$ |
73,003 |
|
NOTE 6 - NOTES PAYABLE
The following table summarizes our outstanding debt as of the dates indicated (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Maturity |
|
Cash Interest Rate |
|
March 31, 2025 |
|
December 31, 2024 |
Notes Payable – Acquisitions(1) |
10/01/25 - 07/01/29 |
|
2.00% - 5.00% |
|
$ |
11,345 |
|
|
$ |
9,943 |
|
Notes Payable – Other |
11/01/25 |
|
10.00% |
|
$ |
5,000 |
|
|
5,000 |
|
Gross Notes Payable |
|
|
|
|
$ |
16,345 |
|
|
$ |
14,943 |
|
(1)See Note 3 — Business Combinations and Asset Acquisitions and Notes Payable - Acquisitions section below for further discussion regarding the notes payable related to acquisitions.
The following table summarizes the debt issuance costs as of the dates indicated (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Notes Payable |
|
Debt Issuance Costs and Debt Discount |
|
Net Notes Payable |
March 31, 2025 |
|
|
|
|
|
Current portion of notes payable |
$ |
8,541 |
|
|
$ |
(593) |
|
|
$ |
7,948 |
|
Notes payable, net of current portion |
7,804 |
|
|
(1,632) |
|
|
6,172 |
|
Total |
$ |
16,345 |
|
|
$ |
(2,225) |
|
|
$ |
14,120 |
|
|
|
|
|
|
|
December 31, 2024 |
|
|
|
|
|
Current portion of notes payable |
$ |
7,578 |
|
|
$ |
(570) |
|
|
$ |
7,008 |
|
Notes payable, net of current portion |
7,365 |
|
|
(1,656) |
|
|
5,709 |
|
Total |
$ |
14,943 |
|
|
$ |
(2,226) |
|
|
$ |
12,717 |
|
The following table summarizes the future principal payments related to our outstanding debt as of March 31, 2025 (in thousands):
|
|
|
|
|
|
2025 (Remaining) |
$ |
7,578 |
|
2026 |
5,767 |
|
2027 |
— |
|
2028 |
— |
|
2029 |
3,000 |
|
Total |
$ |
16,345 |
|
Notes Payable - Acquisitions
As of March 31, 2025, we have seven promissory notes related to acquisitions that occurred during the three months ended March 31, 2025 and prior years with a combined outstanding principal balance of $11,345 and maturity dates ranging from October 1, 2025 to July 1, 2029. See Note 2 — Business Combinations and Asset Acquisitions for further discussion regarding the issuance of notes payable related to acquisitions.
Notes Payable - Other
In November 2024, we delivered a promissory note to an unrelated third party in exchange for cash. As of March 31, 2025, the promissory note had an outstanding principal balance of $5,000 and matures on November 1, 2025. On April 10, 2025, we extinguished this debt using the proceeds of a new credit facility. See Note 12 — Subsequent Events for the details of the extinguishment of this note after the reporting period.
NOTE 7 – CONTRACTS WITH CUSTOMERS AND REVENUE CONCENTRATION
Receivables
Receivables from contracts with customers, net of allowance for credit losses of $6,545, were $15,800 at March 31, 2025. Receivables from contracts with customers, net of allowance for credit losses of $6,328, were $18,154 at December 31, 2024. We had a provision for expected losses of $93, write-offs charged against the allowance for credit losses of $22, and recoveries on previously written off receivables of $145 during the three months ended March 31, 2025. We had a provision for expected losses of $46, write-offs charged against the allowance for credit losses of $3, and recoveries on previously written off receivables of $279 during the three months ended March 31, 2024. No customer represented more than 10% of our net accounts receivable balance as of March 31, 2025 and December 31, 2024, respectively.
Contract Assets
Costs to Fulfill Contracts
Contract assets from contracts with customers were $2,232 and $1,712 at March 31, 2025 and December 31, 2024, respectively.
Costs to Obtain Contracts
Deferred commission costs from contracts with customers were $12,956 and $12,351 at March 31, 2025, and December 31, 2024, respectively. The amount of amortization recognized for the three months ended March 31, 2025, and March 31, 2024, was $737 and $611, respectively.
Deferred Revenue
During the three months ended March 31, 2025 and 2024, revenue of $5,990 and $5,118, respectively, was recognized from the deferred revenue balance at the beginning of each period.
Transaction Price Allocated to the Remaining Performance Obligations
As of March 31, 2025, approximately $82,125 of revenue is expected to be recognized from remaining performance obligations. We expect to recognize revenue on approximately 38% of these remaining performance obligations over the next 12 months, with the balance recognized thereafter. These amounts exclude remaining performance obligations related to contracts for professional services for tax and payroll offerings whose remaining contractual term is less than one year as of March 31, 2025.
Revenue Concentration
During the three months ended March 31, 2025 and 2024, there were no customers that individually represented 10% or more of consolidated revenue.
NOTE 8 - COMMITMENTS AND CONTINGENCIES
Lease Commitments
We have entered into office space lease agreements, which qualify as operating leases under ASU No. 2016-02, “Leases (Topic 842)”. Under such leases, the lessors receive annual minimum (base) rent. The leases have original terms (excluding extension options) ranging from one year to ten years. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.
We record base rent expense under the straight-line method over the term of the lease. In the accompanying Condensed Consolidated Statements of Comprehensive (Loss) Income, rent expense is included in operating expenses under general and administrative expenses. The components of the rent expense are as follows for the periods presented below (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
2025 |
|
2024 |
Operating lease cost |
$ |
534 |
|
|
$ |
531 |
|
Sublease income |
— |
|
|
(5) |
|
Net rent expense |
$ |
534 |
|
|
$ |
526 |
|
For purposes of calculating the operating lease assets and lease liabilities, extension options are not included in the lease term unless it is reasonably certain we will exercise the option, or the lessor has the sole ability to exercise the option. The weighted average discount rate of our operating leases is 10% as of March 31, 2025 and December 31, 2024. The weighted average remaining lease term is four years as of March 31, 2025 and December 31, 2024.
Supplemental cash flow information related to operating leases are as follows for the periods presented below (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
2025 |
|
2024 |
Cash paid for amounts included in the measurement of lease liabilities: |
|
|
|
Operating cash outflows from operating leases |
$ |
564 |
|
|
$ |
500 |
|
Non-cash operating activities: |
|
|
|
Operating lease assets obtained or removed in exchange for new, modified or terminated operating lease liabilities |
$ |
736 |
|
|
$ |
— |
|
Future minimum commitments over the life of all operating leases, which exclude variable rent payments, are as follows for the period presented below (in thousands):
|
|
|
|
|
|
2025 (Remaining) |
$ |
1,472 |
|
2026 |
1,571 |
|
2027 |
1,366 |
|
2028 |
1,188 |
|
2029 |
683 |
|
2030 |
207 |
|
Thereafter |
27 |
|
Total minimum lease payments |
6,514 |
|
Less: imputed interest |
(1,190) |
|
Total lease liabilities |
$ |
5,324 |
|
Contingencies
Although we have been, are, and in the future may be, the defendant or plaintiff in various actions arising in the normal course of business, as of March 31, 2025, we were not currently a party to any material legal proceedings.
NOTE 9 - SHARE-BASED COMPENSATION
We have one active equity plan, the 2018 Incentive Award Plan (the “2018 Plan”). The 2018 Plan, approved by our stockholders, replaced our 2009 Equity Incentive Plan, as amended (the “2009 Plan”); however, the terms and conditions of the 2009 Plan will continue to govern any outstanding awards granted thereunder.
The number of shares reserved for issuance under the 2018 Plan is 4,748 shares. We have an aggregate of 2,809 options, restricted stock units (“RSUs”) and performance stock units (“PSUs”) granted and outstanding pursuant to the 2018 Plan as of March 31, 2025. As of March 31, 2025, the number of shares available for future grant under the 2018 Plan is 163.
Share based compensation for our stock option plans for the three months ended March 31, 2025, and March 31, 2024, was $1,863 and $1,902, respectively. Issuance of common stock related to the exercise of stock options and the vesting of restricted stock units (including restricted stock units that converted from performance stock units) are as follows for the period presented below (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
|
|
|
2025 |
|
2024 |
Common stock issued - options |
|
|
|
|
69 |
|
|
26 |
|
Common stock issued - RSU(1) |
|
|
|
|
382 |
|
|
275 |
|
(1) Included in these amounts are 159 and 109 of restricted stock units that were converted from performance stock units which vested during the three months ended March 31, 2025 and 2024, respectively. |
Effective January 1, 2024, the Compensation Committee approved the grant of PSUs pursuant to a PSU Award Grant Notice and PSU Award Agreement (the “2024 PSU Award Agreement”) under the 2018 Plan to our executive officers payable in the form of RSUs. The number of RSUs into which the PSUs convert for each executive officer is a sliding scale between 0% to 200% of the target amount based on our achievement of certain performance metrics tied to our recurring revenue and gross profit for 2024. On March 6, 2025, the PSUs converted to RSUs at 70% of target based on the achievement of set performance metrics, and we paid out a total of 153 RSUs to our executive officers.
Effective January 1, 2025, the Compensation Committee approved the grant of PSUs pursuant to a PSU Award Grant Notice and PSU Award Agreement (the “2025 PSU Award Agreement”) under the 2018 Plan to our executive officers payable in the form of RSUs. The number of RSUs into which the PSUs convert for each executive officer is a sliding scale between 0% to 200% of the target amount based on our achievement of certain performance metrics tied to our recurring revenue and gross profit for 2025.
NOTE 10 - NET LOSS PER SHARE
We compute net income or loss per share based on the weighted average number of common shares outstanding for the period. Diluted net income per share reflects the maximum dilution that would have resulted from incremental common shares issuable upon the exercise of stock options or vesting of RSUs and in some cases PSUs. In periods of net income, we compute the adjustment to the denominator of our dilutive net earnings per share calculation to include these stock options, RSUs, and PSUs, as applicable, using the treasury stock method. Regardless of the period resulting in net income or net loss, we exclude the adjustment to the denominator of our dilutive net loss per share calculation to the extent that they are anti-dilutive.
The following table sets forth the computation of basic and diluted net loss per common share for the periods presented below (in thousands, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
2025 |
|
2024 |
Basic: |
|
|
|
Net loss |
$ |
(2,398) |
|
|
$ |
(308) |
|
Weighted-average shares of common stock outstanding |
26,961 |
|
|
25,334 |
|
Basic loss per share |
$ |
(0.09) |
|
|
$ |
(0.01) |
|
|
|
|
|
Diluted: |
|
|
|
Net loss |
$ |
(2,398) |
|
|
$ |
(308) |
|
Weighted-average shares of common stock outstanding |
26,961 |
|
|
25,334 |
|
Diluted loss per share |
$ |
(0.09) |
|
|
$ |
(0.01) |
|
NOTE 11 - SEGMENT INFORMATION
We manage our business activities on a consolidated basis and operate as one reportable segment. Our chief operating decision maker (“CODM”) is the Chairman and Chief Executive Officer, who reviews financial information presented on a consolidated basis. The CODM uses consolidated net loss, as reported on our Consolidated Statements of Comprehensive Loss, to assess financial performance and allocate resources. These financial metrics are used by the CODM to make key operating decisions, such as the allocation of budget between cost of sales, sales and marketing, general and administrative, and research and development expenses. The CODM does not review assets in evaluating the results of the segment, and therefore, such information is not presented.
The operating financial results of our single reportable segment for three months ended March 31, 2025, and March 31, 2024, are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
2025 |
|
2024 |
Total revenues |
$ |
34,854 |
|
|
$ |
31,652 |
|
|
|
|
|
Significant segment expenses |
|
|
|
Compensation |
22,788 |
|
|
19,998 |
|
Non-compensation |
9,617 |
|
|
8,249 |
|
Deferred software and commission costs |
(3,372) |
|
|
(2,916) |
|
Amortization, depreciation, and other noncash expenses |
8,128 |
|
|
6,795 |
|
Other segment expenses |
91 |
|
|
(166) |
|
Total expenses |
37,252 |
|
|
31,960 |
|
Net loss |
(2,398) |
|
|
(308) |
|
NOTE 12 - SUBSEQUENT EVENTS
Credit, Security and Guaranty Agreement with MidCap Financial Trust
On April 10, 2025, we entered into a Credit, Security and Guaranty Agreement (the “Loan Agreement”) with MidCap Financial Trust (“MidCap”) and the lenders from time to time party thereto (such lenders collectively with MidCap, the “Lenders”).
Under the Loan Agreement, we may borrow up to $60,000 from the Lenders, with $20,000 funded on April 10. 2025, the closing date of the Loan Agreement (the “Closing Date”). The remaining $40,000 is available through March 31, 2027, in increments of $2,000 (subject to customary notice period requirements), provided that we maintain a Total Leverage Ratio (as defined in the Loan Agreement) of less than 4.50 to 1.00, at the time that we draw funds, and that the funds are used for permitted acquisitions (as defined in the Loan Agreement). The maturity date of the loan as provided under the Loan Agreement is April 1, 2030 (the “Maturity Date”).
Interest on the outstanding loan balance is payable monthly in arrears at an annual rate of Term SOFR plus 5.00%, subject to a Secured Overnight Financing Rate (“SOFR”) floor of 2.00%. Prior to April 1, 2029 (the “Amortization Start Date”), we must make interest-only payments on the outstanding loan balance. Commencing on the Amortization Start Date and continuing on the first day of each calendar month thereafter, we will pay an amount equal to the total principal of the outstanding loan balance divided by twelve (12), for a twelve (12) month straight-line amortization of equal monthly principal payments. Also on a monthly basis, we must pay an administrative agency fee to MidCap equal to 0.25% of the average end-of-day principal balance outstanding during the immediately preceding month.
We are subject to customary events of default as described in the Loan Agreement. In such event, and for so long as it continues, the outstanding loan balance will bear interest at 2.0% per annum in excess of the rate otherwise payable. Under the Loan Agreement, we covenant to maintain a (1) Total Leverage Ratio (as defined in the Loan Agreement), as tested quarterly, no greater than 5.50 to 1.00, and (2) minimum liquidity threshold of 10.00% of the outstanding principal amount of the Loans.
In connection with the Loan Agreement, we incurred $1,954 of origination, legal, and other fees that represent debt financing costs to be deferred and amortized over the duration of the Loan Agreement. As a result, net proceeds of the Loan Agreement were $18,046.
Extinguishment of Third-Party Note Payable
On April 10, 2025, we opted to repay the outstanding balance on our unrelated third-party promissory note (the “Note”) prior to its maturity using the proceeds of the Loan Agreement. In connection with the extinguishment, we paid the lender an aggregate amount of $5,197 (the “Payoff Amount”) in full payment of our outstanding obligations under the Note. The Payoff Amount represented $5,097 of outstanding principal and interest on the unpaid principal balance and a $100 prepayment fee.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains certain statements made by management that may constitute “forward-looking” statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements about our financial results may include expected or projected U.S GAAP and other operating and non-operating results. The words “believe,” “may,” “will,” “estimate,” “projects,” “anticipate,” “intend,” “expect,” “should,” “plan,” and similar expressions are intended to identify forward-looking statements. Examples of “forward-looking statements” include statements we make regarding our operating performance, future results of operations and financial position, revenue growth, earnings or other projections. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties and assumptions, over many of which we have no control. If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, our results could differ materially from the results expressed or implied by the forward-looking statements we make. The risks and uncertainties referred to above include—but are not limited to—risks associated with breaches of our security measures; risks related to material weaknesses; possible fluctuations in our financial and operating results; privacy concerns and laws and other regulations may limit the effectiveness of our applications; the financial and other impact of any previous and future acquisitions; domestic and international regulatory developments, including changes to or applicability to our business of privacy and data securities laws, money transmitter laws and anti-money laundering laws; regulatory pressures on economic relief enacted as a result of the COVID-19 pandemic that change or cause different interpretations with respect to eligibility for such programs; risk of our software and solutions not functioning adequately; interruptions, delays or changes in our services or our Web hosting; may incur debt to meet future capital requirements; volatility and weakness in bank and capital markets; access to additional capital; significant costs as a result of operating as a public company; the expiration of Employee Retention Tax Credits (“ERTC”) and the impact of the Internal Revenue Service recent measures regarding ERTC claims and the corresponding cash collections of existing receivables; the inability to continue to release timely updates for changes in laws; the inability to develop new and improved versions of our services and technological developments; customer’s nonrenewal of their agreements and other similar changes could negatively impact revenue, operating results and financial conditions; the exposure of market, interest, credit and liquidity risk on client funds held int rust; our operation in highlight competitive markets; risk that our clients could have insufficient funds that could result in limitations in the ability to transmit ACH transactions; impairment of intangible assets; litigation and any related claims, negotiations and settlements, including with respect to intellectual property matters or industry-specific regulations; various financial aspects of our Software-as-a-Service model; adverse effects to our business a result of claims, lawsuits, and other proceedings; issues in the use of artificial intelligence in our HCM products and services; adverse changes to financial accounting standards to us; inability to maintain third-party licensed software; evolving regulation of the Internet, changes in the infrastructure underlying the Internet or interruptions in Internet; factors affecting our deferred tax assets and ability to value and utilize them; the nature of our business model; inability to adopt new or correctly interpret existing money service and money transmitter business status; our ability to hire, retain and motivate employees and manage our growth; interruptions to supply chains and extended shut down of businesses; potential enactment of adverse tax laws, regulation, political, economic and social factors; potential sales of a substantial number of shares of our common stock along with its volatility; risks associate with potential equity-related transactions including dividends, rights under the stockholder plan to discourage certain actions and other impacts as a result of actions of our stockholders.
Further information on these and other factors that could affect our financial results is included in the reports on Forms 10-K, 10-Q and 8-K, and in other filings we make with the Securities and Exchange Commission (the “SEC”) from time to time. These documents are available on the SEC Filings section of the Investor Information section of our website at investor.asuresoftware.com. Asure assumes no obligation and does not intend to update these forward-looking statements, except as required by law.
OVERVIEW
The following review of Asure’s financial position as of March 31, 2025 and December 31, 2024, and results of operations for the three months ended March 31, 2025 and 2024 should be read in conjunction with our 2024 Annual Report on Form 10-K filed with the SEC on March 6, 2025. Our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are available through the investor relations page of our internet website free of charge as soon as reasonably practicable after they are electronically filed, or furnished to, the SEC. Asure’s internet website and the information contained in our website or connected to our website are not incorporated into this Quarterly Report on Form 10-Q. However, we do post information on the investor relations page of our website that we believe may be of interest to our investors. Asure’s internet website address is www.asuresoftware.com.
Our Business
We are a provider of cloud-based Human Capital Management (“HCM”) software solutions delivered as Software-as-a-Service (“SaaS”) to businesses of all sizes. We offer human resources (“HR”) tools necessary to build a thriving workforce, provide the resources to stay compliant with dynamic federal, state, and local tax jurisdictions and their respective labor laws, freeing cash flows so these businesses can spend their financial capital on growing their businesses rather than administrative overhead that can impede growth. Our solutions also provide new ways for employers to connect with their employees and strengthen relationships with their talent. At the core of our offering is the Asure HCM platform—a SaaS-based system that includes Payroll & Tax filing, Recruiting, Time & Attendance software, HR management tools, and Benefits Administration. This platform serves as the foundation for delivering both our core software and a range of complementary, technology-enabled services. These include AsureMarketplace™, which automates data exchange between our HCM system and third-party providers to increase efficiency, accuracy, and breadth of services. Our HR Compliance services combine expert guidance with scalable digital delivery. AsurePay™, our Visa-branded payroll card, provides employees with fast, secure access to earned wages. Additionally, through our licensed brokerage, we offer Insurance Services that help employers manage benefits and reduce administrative costs. We deliver our solutions directly and through a national network of Reseller Partners.
We strive to be the most trusted HCM resource. Our solutions solve three primary challenges that prevent businesses from growing: HR complexity, allocation of human and financial capital, and the ability to build great teams. We sell our solutions through both direct and partner channels. We supplement our direct sales efforts with partner programs that afford us access to opportunities in various geographic and industry niches. Asure has two types of partners: Reseller Partners that white label our products while providing value-added services to their clients (our indirect clients) and Referral Partners that provide us with client leads but do not resell our solutions. We have and will continue to invest in research and development to expand our solutions. Our solutions reduce the administrative burden on employers and increase employee productivity while managing the employment lifecycle. The Asure HCM suite includes eight product lines: Asure Payroll & Tax, Asure Tax Management Solutions, AsureRecruiting™, Asure Time & Attendance, Asure HR Compliance, Asure Insurance and Benefits Administration, AsureMarketplace™, and AsurePay™.
From recruitment to retirement, our solutions help more than 100,000 clients across the United States. Approximately 20% of our clients are direct and the remaining clients are indirect, as they have contracts with reseller partners who white label our solutions.
RESULTS OF OPERATIONS (in thousands)
The following table sets forth, for the fiscal periods indicated, the percentage of total revenue represented by certain items in our Condensed Consolidated Statements of Comprehensive Loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
|
2025 |
|
2024 |
Revenue |
|
100 |
% |
|
100 |
% |
Gross profit |
|
71 |
% |
|
71 |
% |
Sales and marketing |
|
24 |
% |
|
25 |
% |
General and administrative |
|
34 |
% |
|
32 |
% |
Research and development |
|
6 |
% |
|
6 |
% |
Amortization of intangible assets |
|
12 |
% |
|
11 |
% |
Total operating expenses |
|
76 |
% |
|
73 |
% |
Interest income |
|
— |
% |
|
1 |
% |
Interest expense |
|
(1) |
% |
|
(1) |
% |
Other income, net |
|
1 |
% |
|
— |
% |
Loss from operations before income taxes |
|
(6) |
% |
|
(1) |
% |
Net loss |
|
(7) |
% |
|
(1) |
% |
Revenue
Revenue is comprised of recurring revenue, professional services, hardware, and other revenue. We expect our revenue to increase as we introduce new applications, expand our client base and renew and expand relationships with existing clients. As a percentage of total revenue, we expect our mix of recurring revenue, and professional services, hardware and other revenue to remain relatively constant. While revenue mix varies by product, recurring revenue consistently represented over 95% of total revenue in three months ended March 31, 2025, and 2024.
Our revenue was derived from the following sources (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
Variance |
|
2025 |
|
2024 |
|
$ |
|
% |
Recurring |
$ |
33,187 |
|
|
$ |
30,273 |
|
|
$ |
2,914 |
|
|
10 |
% |
Professional services, hardware and other |
1,667 |
|
|
1,379 |
|
|
288 |
|
|
21 |
% |
Total |
$ |
34,854 |
|
|
$ |
31,652 |
|
|
$ |
3,202 |
|
|
10 |
% |
Recurring Revenue
Recurring revenues include fees for our payroll and tax management, recruiting services, HR compliance, time and labor management, insurance and benefits administration, AsureMarketplace™ and other Asure solutions as well as fees charged for form filings and delivery of client payroll checks and reports. These revenues are derived from fixed amounts charged per billing period and sometimes an additional fee per employee or transaction processed. We do not require clients to enter into long-term contractual commitments for our services. Our billing period varies by client based on when each client pays its employees, which may be weekly, bi-weekly, semi-monthly or monthly. We also generate recurring revenues from our Reseller Partners that license our solutions. Because recurring revenues are based, in part, on fees for use of our applications and the delivery of checks and reports that are levied on a per-employee basis, our recurring revenues increase as our clients hire more employees. Recurring revenues are recognized in the period services are rendered.
Recurring revenues include revenues relating to the annual processing of payroll forms, such as Form W-2 and Form 1099, and revenues from processing unscheduled payroll runs (such as bonuses) for our clients. Because payroll forms are typically processed in the first quarter of the year and many of our clients are subject to form filing requirements mandated by the ACA, first quarter revenues and margins are generally higher than in subsequent quarters. We anticipate our revenues will continue to exhibit this seasonal pattern related to Affordable Care Act (“ACA”) form filings for so long as the ACA (or replacement legislation) includes employer reporting requirements. In addition, we often experience increased revenues during the fourth quarter due to unscheduled payroll runs for our clients that occur before the end of the year. We expect the seasonality of our revenue cycle to decrease to the extent clients utilize more of our non-payroll applications.
This revenue line also includes interest earned on funds held for clients. Interest earned is generated from funds we collect from clients in advance of either the applicable due date for payroll tax submissions or the applicable disbursement date for employee payment services. These collections from clients are typically disbursed from one to 30 days after receipt, with some funds being held for up to 120 days. We typically invest funds held for clients in money market funds, demand deposit accounts, commercial paper, fixed income securities and certificates of deposit until they are paid to the applicable tax or regulatory agencies or to client employees. The amount of interest we earn from the investment of client funds is also impacted by changes in interest rates.
Recurring revenue for the three months ended March 31, 2025 was $33,187, an increase of $2,914, or 10%, from $30,273 for the three months ended March 31, 2024. The increase is primarily due to an increase tax management solutions.
Professional Services, Hardware and Other Revenue
Professional Services, Hardware and Other Revenues represents implementation fees, one-time consulting projects, on-premise maintenance, hardware devices to enhance our software products as well as ERTC revenues that are transactional in nature.
Professional services, hardware and other revenue increased $288, or 21%, for the three months ended March 31, 2025 from the similar period in 2024, primarily due to an increase in professional services, offset with a decrease in non-recurring ERTC revenue. Refer to “Risk Factors” previously disclosed in our Annual Report on Form 10-K, filed with the SEC on March 6, 2025, for more information about risks related to our ERTC business.
Our total customer base is widely spread across industries and sizes. Geographically, we sell our products primarily in the United States.
In addition to continuing to develop our workforce solutions and release of new software updates and enhancements, we continue to actively explore other opportunities to acquire additional products or technologies to complement our current software and services.
Gross Profit and Gross Margin
Consolidated gross profit for the three months ended March 31, 2025, was $24,608, an increase of $2,001, or 9%, from $22,607 for the three months ended March 31, 2024. Gross margin as a percentage of revenue remained consistent at 71% for the three months ended March 31, 2025, and 2024.
Our cost of sales relates primarily to direct product costs, compensation for operations and related consulting expenses, hardware expenses, facilities and related expenses and the amortization of our purchased software development costs. We include intangible amortization related to developed and acquired technology within cost of sales.
Sales and Marketing Expenses
Sales and marketing expenses primarily consist of salaries and related expenses for sales and marketing staff, including stock-based expenses, commissions, as well as marketing programs, which include events, corporate communications and product marketing activities.
Sales and marketing expenses for the three months ended March 31, 2025 were $8,386, an increase of $619, or 8%, from $7,767 for the three months ended March 31, 2024. The increase is primarily due to an increase in compensation to direct sales personnel and external referral partners, partially offset by a decrease in marketing initiatives. Sales and marketing expenses as a percentage of revenue decreased to 24% for the three months ended March 31, 2025 from 25% for the same period in 2024.
We expect to continue to expand and increase selling costs as we focus on hiring direct sales personnel, expanding recognition of our brand, and lead generation.
General and Administrative Expenses
General and administrative expenses primarily consist of salaries and related expenses, including stock-based expenses for finance and accounting, legal, internal audit, human resources and management information systems personnel, legal costs, professional fees, and other corporate expenses such as transaction costs for acquisitions.
General and administrative expenses for the three months ended March 31, 2025 were $11,900, an increase of $1,837, or 18%, from $10,063 for the three months ended March 31, 2024. The increase is primarily attributable to increased personnel compensation expenses along with higher service costs associated with regulatory compliance and transactions. General and administrative expenses as a percentage of revenue increased to 34% for the three months ended March 31, 2025 from 32% for the same period in 2024.
Research and Development Expenses
Research and development (“R&D”) expenses consist primarily of salaries and related expenses, including stock-based expenses for employees supporting our R&D activities.
R&D expenses for the three months ended March 31, 2025 were $2,029, an increase of $260, or 15%, from $1,769 for the three months ended March 31, 2024. The increase is primarily attributable to an increase personnel compensation expenses and partially offset by an increase in capitalization of software expenses for continued investment in the development of our products. R&D expenses as a percentage of revenue remained flat at 6% for the three months ended March 31, 2025 compared to the same period in 2024.
Amortization of Intangible Assets
Amortization expense for the three months ended March 31, 2025 was $4,308, an increase of $859, or 25%, from $3,449 for the three months ended March 31, 2024. The increase in amortization expense is primarily attributable to increased acquisition activity compared to the prior year. Amortization expense as a percentage of revenue increased to 12% for the three months ended March 31, 2025 from 11% for the same period in 2024.
Interest Income and Expense
Interest income for the three months ended March 31, 2025 was $171 compared to interest income of $336 for the three months ended March 31, 2024. Interest income as a percentage of revenue was negligible for the three months ended March 31, 2025, compared to 1% for the three months ended March 31, 2024. Interest expense for the three months ended March 31, 2025 was $451 compared to interest expense of $180 for the three months ended March 31, 2024. Interest expense as a percentage of revenue was 1% for the three months ended March 31, 2025 and 2024.
Other Income, Net
Other income, net for the three months ended March 31, 2025 was $188 compared to $10 for the three months ended March 31, 2024. Other income, net as a percentage of revenue was 1% for the three months ended March 31, 2025, and negligible for the three months ended March 31, 2024. The increase is primarily attributable to the receipt of incremental ERTC refundable tax credit paid by the IRS for our original claim.
Income Taxes
For the three months ended March 31, 2025 and 2024, we recorded income tax expense attributable to continuing operations of $291 and $33, respectively, an increase of $258.
Net Loss
We incurred a loss of $2,398, or $0.09 per share, during the three months ended March 31, 2025, compared to a loss of $308, or $0.01 per share, during the three months ended March 31, 2024. Loss as a percentage of total revenue was 7% and 1% for the three months ended March 31, 2025 and 2024, respectively.
LIQUIDITY AND CAPITAL RESOURCES (in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
December 31, 2024 |
Cash and cash equivalents |
$ |
14,076 |
|
|
$ |
21,425 |
|
(1)This balance excludes cash equivalents in funds held for clients.
Working Capital. We had working capital of $9,000 at March 31, 2025, a decrease of $4,641 from working capital of $13,641 at December 31, 2024. Working capital as of March 31, 2025 and December 31, 2024 includes $4,662 and $8,363 of short-term deferred revenue, respectively. Deferred revenue is an obligation to perform future services. We expect that deferred revenue will convert to future revenue as we perform our services, but this does not represent future payments. Deferred revenue can vary based on seasonality, expiration of initial multi-year contracts and deals that are billed after implementation rather than in advance of service delivery.
Operating Activities. Net cash provided by operating activities of $1,996 for the three months ended March 31, 2025 was primarily driven by non-cash adjustments to our net loss of approximately $8,277, primarily due to depreciation and amortization and share-based compensation. This was offset by changes in operating assets and liabilities, which resulted in a use of $3,883 in cash. Net cash used in operating activities of $3,947 for the three months ended March 31, 2024 was driven by non-cash adjustments to our net loss of approximately $6,579, primarily due to depreciation and amortization and share-based compensation. For the three months ended March 31, 2024, changes in operating assets and liabilities resulted in a use of $10,218 in cash.
Investing Activities. Net cash used in investing activities of $12,630 for the three months ended March 31, 2025 is primarily due to purchases of available-for-sale securities and maturities of $6,589 and intangible assets of $6,346, offset by proceeds from sales and maturities of available-for-sale securities of $3,266. Net cash used in investing activities of $4,495 for the three months ended March 31, 2024 is primarily due to purchases of available-for-sale securities and maturities of $3,516.
Financing Activities. Net cash provided by financing activities was $63,925 for the three months ended March 31, 2025, which primarily consisted of a net increase in client fund obligations of $64,207. Net cash provided by financing activities was $21,062 for the three months ended March 31, 2024, which primarily consisted of a net increase in client fund obligations of $21,122.
We also had an outstanding promissory note with an unrelated third party intended to fund future acquisitions and for general working capital purposes from November 2024 in the amount of $5,000 as of March 31, 2025. On April 10, 2025, the note was paid off in full alongside a $100 prepayment fee using the proceeds of the new credit facility described below.
As of March 31, 2025, we have seven subordinated promissory notes related to acquisitions that occurred during the three months ended March 31, 2025 and prior years with a combined outstanding principal balance of $11,345 and maturity dates ranging from October 1, 2025 to July 1, 2029.
On April 10, 2025, we entered into a Credit, Security and Guaranty Agreement (the “Loan Agreement”) with MidCap Financial Trust (“MidCap”) and the lenders from time to time party thereto (such lenders collectively with MidCap, the “Lenders”).
Under the Loan Agreement, we may borrow up to $60,000 from the Lenders, with $20,000 funded on April 10. 2025, the closing date of the Loan Agreement (the “Closing Date”). The remaining $40,000 is available through March 31, 2027, in increments of $2,000 (subject to customary notice period requirements), provided that we maintain a Total Leverage Ratio (as defined in the Loan Agreement) of less than 4.50 to 1.00, at the time that we draw funds, and that the funds are used for permitted acquisitions (as defined in the Loan Agreement). The maturity date of the loan as provided under the Loan Agreement is April 1, 2030 (the “Maturity Date”).
Interest on the outstanding loan balance is payable monthly in arrears at an annual rate of Term SOFR plus 5.00%, subject to a Secured Overnight Financing Rate (“SOFR”) floor of 2.00%. Prior to April 1, 2029 (the “Amortization Start Date”), we must make interest-only payments on the outstanding loan balance. Commencing on the Amortization Start Date and continuing on the first day of each calendar month thereafter, we will pay an amount equal to the total principal of the outstanding loan balance divided by twelve (12), for a twelve (12) month straight-line amortization of equal monthly principal payments. Also on a monthly basis, we must pay an administrative agency fee to MidCap equal to 0.25% of the average end-of-day principal balance outstanding during the immediately preceding month.
We are subject to customary events of default as described in the Loan Agreement. In such event, and for so long as it continues, the outstanding loan balance will bear interest at 2.0% per annum in excess of the rate otherwise payable. Under the Loan Agreement, we covenant to maintain a (1) Total Leverage Ratio (as defined in the Loan Agreement), as tested quarterly, no greater than 5.50 to 1.00, and (2) minimum liquidity threshold of 10.00% of the outstanding principal amount of the Loans.
In connection with the Loan Agreement, we incurred $1,954 of origination, legal, and other fees that represent debt financing costs to be deferred and amortized over the duration of the Loan Agreement. As a result, net proceeds of the Loan Agreement were $18,046.
Sources of Liquidity. As of March 31, 2025, our principal sources of liquidity consisted of approximately $14,076 of cash and cash equivalents, cash generated from operations of our business over the next twelve months, and the net proceeds from our Loan Agreement received on April 10, 2025. We also have the ability to obtain an additional $40,000 from the Loan Agreement. With respect to future advances under the Loan Agreement, we must use such proceeds for acquisitions. Additionally, we have access to an “at the market offering” program entered in October 31, 2024, under which we may offer and sell up to $25,000 of newly issued common stock. As of March 31, 2025, there are $25,000 of shares of common stock available for issuance under the program.
We cannot ensure that we can grow our cash balances or limit our cash consumption and thus maintain sufficient cash balances for our planned operations or future acquisitions; however, we do believe that we have sufficient liquidity to support our business operations for at least the next twelve months. Future business demands may lead to cash utilization at levels greater than recently experienced or expected. We may need to raise additional capital in the future in order to grow our existing software operations and to seek additional strategic acquisitions in the near future. . Further, we cannot ensure that we will be able to raise additional capital on acceptable terms, or at all, or at the time we need it.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of the assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are subjective in nature and involve judgments that affect the amounts reported. The Condensed Consolidated Financial Statements and the Notes to the Condensed Consolidated Financial Statements in Item 1 of this Form 10-Q, and the Notes to the Consolidated Financial Statements in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2024, describe the significant accounting policies and methods used in the preparation of our consolidated financial statements. There have been no material changes to our critical accounting estimates included in our Annual Report on Form 10-K for the year ended December 31, 2024.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes to our exposure from market risks from those disclosed in our 2024 Annual Report on Form 10-K.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Control and Procedures
Our management, with the participation of our chief executive officer and chief financial officer evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Exchange Act, as of March 31, 2025. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the United States Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosure.
In connection with our chief executive officer and chief financial officer’s review of the disclosure controls and procedures for our Annual Report on Form 10-K for the year ended December 31, 2024, our management concluded that there was a material weakness in our disclosure controls and procedures as described below.
Based on the evaluation of our disclosure controls and procedures as of March 31, 2025, our chief executive officer and chief financial officer concluded that, as of such date, our disclosure controls and procedures were not effective at the reasonable assurance level because of the existence of a material weakness as described below. Notwithstanding the material weakness in our internal control over financial reporting described below, management believes that the consolidated financial statements and related financial information included in this Quarterly Report on Form 10-Q fairly present in all material respects our financial condition, results of operations, and cash flows as of the dates presented, and for the periods ended on such dates, in conformity with accounting principles generally accepted in the United States of America.
Identified Material Weakness
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.
Our management identified that as of December 31, 2024, we had ineffective design and operation of controls over program change management due to a lack of complete program and data change logs for certain financially relevant applications. Automated process-level and manual controls that are dependent upon the information derived from such financially relevant systems were determined to be ineffective as a result of such deficiency.
The material weakness did not result in a material misstatement to our consolidated financial statements, however, the control deficiency described above created a reasonable possibility that a material misstatement to the consolidated financial statements would not be prevented or detected on a timely basis. We concluded that the deficiency represents a material weakness in our internal control over financial reporting and that our disclosure controls and procedures were not effective as of December 31, 2024.
Management’s Plan to Remediate the Identified Material Weakness
The above-described material weakness has not been fully remediated as of the filing of this Quarterly Report on Form 10-Q. Since identifying the material weakness described above, management, with oversight from the Audit Committee, has begun to implement enhanced policies, including changes to completely capture program and data change logs. These controls and procedures are intended to address the identified material weakness and to enhance our overall internal control over financial reporting. Specifically, we have configured our back-ups for our production environment to retain complete program and data change logs. We also intends to implement automated tracking tools to ensure that all program and data changes are recorded and logged.
As management continues to evaluate and improve our internal control over financial reporting and disclosure controls and procedures, management may determine to take additional measures to improve controls and determine to modify the remediation plan described above. We are working to remediate the material weakness as efficiently and effectively as possible, but the material weakness cannot be considered fully remediated until the updated policies and changes to the production environment have been in place and operated for a sufficient period of time to enable management to conclude, through testing, that these controls are designed and operating effectively. Accordingly, management will continue to monitor and evaluate the effectiveness of our internal control over financial reporting in the activities affected by the material weakness described above.
Change in Internal Controls over Financial Reporting
Other than the material weakness and remediation plan discussed above, there have been no other changes in our internal control over financial reporting (as defined in Rules 13a-15(f) or 15d-15(f) of the Exchange Act) that occurred during the period ended March 31, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We have been, and in the future may be, the defendant or plaintiff in various actions arising in the normal course of business. As of March 31, 2025, we were not party to any material legal proceedings.
ITEM 1A. RISK FACTORS
We have updated certain of the risk factors described in Part I, Item 1A. “Risk Factors” in our 2024 Annual Report on Form 10-K (the “Risk Factors”) to reflect the entering of the Credit, Security and Guaranty Agreement with MidCap Financial Trust. The Risk Factors, as updated below, should be carefully considered, together with the other information contained or incorporated by reference in this Quarterly Report on Form 10-Q and in our other filings with the SEC, in connection with evaluating the Company, our business, and the forward-looking statements contained in this Quarterly Report on Form 10-Q. Other risks that we do not presently know about or that we presently believe are not material could also adversely affect us. The risk factors described below update the risk factors disclosed in Part I, Item 1A. in our 2024 Annual Report on Form 10-K to include additional information, and should be read in conjunction with the risk factors in our 2024 Annual Report on Form 10-K.
Our ability to make scheduled payments on or to refinance our existing indebtedness (including the indebtedness under our Credit, Security and Guaranty Agreement with MidCap Financial Trust and our subordinated promissory notes) depends on our future performance, which is subject to economic, financial, competitive and other factors that may be beyond our control.
Our business may not generate cash flow from operations in the future sufficient to service our debt and support our growth strategies. If we are unable to generate sufficient cash flow, we may be required to pursue one or more alternatives, such as selling assets, restructuring debt or obtaining additional equity capital on terms that may be onerous or dilutive. Our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities or on desirable terms, which could result in a default on our debt obligations, including under our current debt obligations. In addition, if for any reason we are unable to meet our debt service and repayment obligations, we would be in default under the terms of our Credit, Security and Guaranty Agreement with MidCap Financial Trust, which would allow our creditors at that time to declare all outstanding indebtedness to be due and payable. Under these circumstances, our lenders could compel us to apply all of our available cash to repay our indebtedness.
Our ability to incur debt and the use of our funds could be limited by the restrictive covenants in our loan agreement for our term loan and credit facility.
Our agreement with MidCap Financial Trust provides for a credit facility that contains restrictive covenants, including restrictions on our ability to pay dividends to stockholders, as well as requirements to comply with certain leverage ratios and other financial maintenance tests and stringent requirements around regulatory compliance. These restrictive covenants and requirements limit the amount of borrowings that are available to us. The agreement covenants may also affect our ability to obtain future financing and to pursue attractive business opportunities and our flexibility in planning for, and reacting to, changes in business conditions. These covenants could place us at a disadvantage compared to some of our competitors, who may have fewer restrictive covenants and may not be required to operate under these restrictions. Further, the proceeds from our credit facility are only available for use in connection with permitted acquisitions (as defined in the Loan Agreement), which means the funds may not be used for general corporate purposes and thus may not be available when we need them.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
None.
ITEM 5. OTHER INFORMATION
On April 16, 2025, the Board of Directors of the Company approved a Fourth Amended and Restated Rights Agreement (the “Fourth Amended Rights Agreement”), by and between the Company and Equiniti Trust Company LLC to be dated effective October 28, 2025. The effectiveness of the Fourth Amended Rights Agreement is subject to the approval of a majority of the shares of common stock present in person or represented by proxy at our 2025 Annual Meeting of Stockholders, which will be held on June 2, 2025.
During the three months ended March 31, 2025, none of our directors or officers have entered into, amended or
terminated a 10b5-1 trading plan.
ITEM 6. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
(a)The following documents are filed as a part of this Quarterly Report on Form 10-Q:
(1)Financial Statements:
The Financial Statements required by this item are submitted in Part II, Item 8 of this report.
(2)Financial Statement Schedules:
All schedules are omitted because they are not applicable, or the required information is shown in the Financial Statements or in the notes thereto.
(3)Exhibits:
|
|
|
|
|
|
|
|
|
EXHIBIT NUMBER |
|
DESCRIPTION |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit, Security and Guaranty Agreement, dated as of April 10, 2025, by and among Asure Software, Inc., Asure Operations LLC, Asure Customer & IP Holdco LLC, Asure Payroll Tax Management LLC, Asure Benefits Management LLC, Asure Treasury Management, LLC MidCap Financial Trust and the lenders from time to time party hereto (Previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 1-34522), filed April 10, 2025).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101 |
|
The following materials from Asure Software, Inc.’s Condensed Quarterly Report on Form 10-Q for the three months ended March 31, 2025, formatted in Inline XBRL: (1) the Condensed Consolidated Balance Sheets, (2) the Condensed Consolidated Statements of Comprehensive Loss, (3) the Condensed Consolidated Statements of Changes in Stockholders’ Equity, (4) the Condensed Consolidated Statements of Cash Flows, and (5) Notes to Condensed Consolidated Financial Statements (filed herewith). |
|
|
|
104 |
|
The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, formatted as Inline XBRL and contained in Exhibit 101 (filed herewith). |
* Filed herewith.
** Furnished herewith.
+ Indicates management contract or compensatory plan, contract or arrangement in which directors or executive officers participate.
++ Certain schedules and similar attachments to this agreement have been omitted pursuant to Item 601(a)(5) of Rule S-K. Asure undertakes to furnish supplementally a copy of all omitted schedules and attachments to the Securities and Exchange Commission upon its request.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
ASURE SOFTWARE, INC. |
|
|
|
|
|
Date: May 1, 2025 |
By: |
/s/ PATRICK GOEPEL |
|
|
|
Patrick Goepel |
|
|
|
Chief Executive Officer |
|
|
|
(Principal Executive Officer) |
|
|
|
|
|
Date: May 1, 2025 |
By: |
/s/ JOHN PENCE |
|
|
|
John Pence |
|
|
|
Chief Financial Officer |
|
|
|
(Principal Financial and Accounting Officer) |
|
EX-10.1
2
a20250331exhibit101.htm
EX-10.1
Document
ASURE SOFTWARE, INC.
2018 INCENTIVE AWARD PLAN
PERFORMANCE STOCK UNIT AWARD GRANT NOTICE
Asure Software, Inc., a Delaware corporation, (the “Company”), pursuant to its 2018 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (the “Participant”), an award of performance stock units (“Performance Stock Units” or “PSUs”). This award of Performance Stock Units is subject to all of the terms and conditions set forth in this Grant Notice, in the Performance Stock Unit Award Agreement attached as Exhibit A (the “Agreement”) and the Plan, each of which are incorporated herein by reference. Unless otherwise defined in this Grant Notice, capitalized terms used in this Grant Notice or the Agreement shall have the meanings ascribed to them in the Plan.
|
|
|
|
|
|
Participant: |
|
|
|
Grant Date: |
January 1, 2025 |
|
|
Performance Period: |
January 1, 2025 through December 31, 2025 |
|
|
Target Award: |
___________ PSUs |
|
|
Final Award: |
Target Award, multiplied by the Payout Percentage based on the achievement of the Performance Metrics. |
|
|
Payment of Final Award: |
Asure will pay the Final Award as soon as practicable and no later than March 15, 2026 (such date of payment, begin the “Final Payment Date”). The Final Award shall be paid in Restricted Stock Units (the “RSUs”) at a conversion rate of 1 PSU equals 1 RSU. The RSUs will vest in installments as follows: (a) 38.89% of the RSUs will vest on the Final Payment Date if the Final Payment Date is in February 2026 or 41.67% of the RSUs will vest on the Final Payment Date if the Final Payment Date is in March 2026; and (b) the remaining RSUs will vest in equal monthly installments beginning on the first day of the calendar month after the Final Payment Date through and including January 1, 2028. |
|
|
RSU Conversion: |
Each vested RSU will convert into one share of the common stock of Asure Software, Inc. |
|
|
Termination: |
If the Participant experiences a Termination of Service before the Final Payment Date, all PSUs shall be automatically forfeited by the Participant without payment of any consideration therefor. If the Participant experiences a Termination of Service after the Final Payment Date, any RSUs that have not vested on or prior to the date of such Termination of Service will thereupon be automatically forfeited by the Participant without payment of any consideration therefor. |
By his or her signature and the Company’s signature below, the Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and this Grant Notice. The Participant has reviewed the Plan, the Agreement and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of the Plan, the Agreement and this Grant Notice. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, the Agreement or this Grant Notice.
In addition, by signing below, the Participant also agrees that the Company, in its sole discretion, may satisfy any withholding obligations in accordance with Section 2.10(b) of the Agreement by (i) withholding shares of Common Stock otherwise issuable to the Participant upon vesting of the RSUs, (ii) instructing a broker on the Participant’s behalf to sell shares of Common Stock otherwise issuable to the Participant upon vesting of the RSUs and submit the proceeds of such sale to the Company, or (iii) using any other method permitted by Section 2.6 of the Agreement or the Plan.
|
|
|
|
|
|
|
|
|
Participant: |
|
PARTICIPANT: |
|
|
|
ASURE SOFTWARE, INC. |
|
|
|
|
|
By: _________________________________ |
|
By: _________________________________ |
Print Name: Patrick Goepel |
|
Print Name: |
Title: Chief Executive Officer |
|
|
EXHIBIT A
PERFORMANCE STOCK UNIT AWARD AGREEMENT
This Performance Stock Unit Agreement (this “Agreement”), dated as of the Grant Date set forth in the Performance Stock Unit Award Grant Notice (the “Grant Notice,”) is made between Asure Software, Inc. (the “Company”) and the Participant. The Grant Notice is included in, and made part of, this Agreement.
ARTICLE 1
GENERAL
1.1 Defined Terms. Capitalized terms not specifically defined in this Agreement shall have the meanings specified in the Plan and the Grant Notice.
1.2 Incorporation of Terms of Plan. The PSUs are subject to the terms and conditions of the Plan, which are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control.
ARTICLE 2
PERFORMANCE CRITERIA AND AWARD DETERMINATION
2.1 Target Award Grant. Subject to the provisions of this Agreement and the Plan, the Company hereby grants to Participant the number of performance stock units (“Performance Stock Units” or “PSUs”) set forth in the Grant Notice (the “Target Award”).
2.2 Final Award Determination. At the end of the Performance Period and subject to the achievement of the performance metrics set forth in Section 2.3 (the “Performance Metrics”), the Participant shall be entitled to receive that number of restricted stock units (the “Restricted Stock Units” or “RSUs”) equal to (i) the Target Award, multiplied by (ii) the Payout Percentage (the “Final Award”). The Payout Percentage shall be calculated with reference to Schedule 1 after the achievement of the Performance Metrics are certified in writing by the Compensation Committee of the Company’s Board of Directors (the “Committee”) following completion of the audit of the Company’s financial statements for the period ending on the last day of the Performance Period.
2.3 Performance Metrics. The Performance Metrics are (i) recurring revenue, and (ii) gross profit. Recurring revenue shall be determined in accordance with generally accepted accounting practices and as set forth in the Company’s audited Consolidated Statements of Comprehensive Income (Loss) for the period ending on the last day of the Performance Period and subject to such exclusions and adjustments in each case as set forth on Schedule 1 or as determined by the Committee and communicated to the Participant in writing, when determined. Gross profit shall be determined in a manner generally consistent with the Company’s calculation of non-GAAP gross profit for the period ending on the last day of the Performance Period and included in the Company’s earnings release for such period, also subject to such exclusions and adjustments in each case as set forth on Schedule 1 or as determined by the Committee and communicated to the Participant in writing, when determined. The Committee has established the base threshold, target and maximum values for each Performance Metric, which are set forth on Schedule 1. The Committee may modify such threshold, target and maximum values for any Performance Metric to account for changed circumstances in the Company’s business occurring during the Performance Period, including, without limitation, acquisitions, new lines of business, divestitures, audit adjustments or changes in business lines.
2.4 Performance Period. The Performance Period, for purposes of this Agreement, shall be determined by the Compensation Committee and shall be the period set forth in the Grant Notice.
2.5 Settlement of Final Award. As soon as reasonably practicable following the completion of the Company’s annual audit of its financial statements for the year ended on the last day of the Performance Period and no later than March 15 of the year following the year in which the Performance Period ends, the Committee shall certify the achievement of the Performance Metrics, determine the Final Award and issue RSUs to each Participant in the amount of the Final Award. Each RSU shall be equivalent to one share of the common stock of the Company.
2.6 Unsecured Obligation to RSUs. Unless and until the PSUs have been earned and the Final Award determined, the RSUs have been issued and the RSUs have vested in the manner set forth in Section 2.7 of this Agreement, the Participant will have no right to receive Common Stock under any such RSUs. Prior to actual payment of any vested RSUs, such RSUs will represent an unsecured obligation of the Company, payable (if at all) only from the general assets of the Company.
2.7 Vesting Schedule. Subject to Section 2.9 and 2.14 of this Agreement, the RSUs issued in connection with the payment of the Final Award shall vest and become nonforfeitable with respect to the applicable portion thereof according to the vesting schedule set forth in the Grant Notice (rounding down to the nearest whole Share).
2.8 Consideration to the Company. In consideration of the grant of the award of PSUs pursuant hereto, the Participant agrees to render faithful and efficient services to the Company or any Subsidiary.
2.9 Forfeiture, Termination and Cancellation upon Termination of Service. Notwithstanding any contrary provision of this Agreement or the Plan, upon the Participant’s Termination of Service for any or no reason, any PSUs that have not been earned and any RSUs, which have not vested prior to or in connection with such Termination of Service shall thereupon automatically be forfeited, terminated and cancelled as of the applicable termination date without payment of any consideration by the Company, and the Participant, or the Participant’s beneficiary or personal representative, as the case may be, shall have no further rights hereunder. No portion of the PSUs which have not been earned and the RSUs issued in connection with a Final Award and which have not become vested as of the date on which the Participant incurs a Termination of Service shall thereafter become vested.
2.10 Issuance of Common Stock upon Vesting.
(a) As soon as administratively practicable following the vesting of any Restricted Stock Units pursuant to Section 2.7 of this Agreement, but in no event later than 30 days after such vesting date (for the avoidance of doubt, this deadline is intended to comply with the “short term deferral” exemption from Section 409A of the Code), the Company shall deliver to the Participant, a number of Shares equal to the number of RSUs subject to this Award that vest on the applicable vesting date. Notwithstanding the foregoing, in the event Shares cannot be issued pursuant to Section 10.7 of the Plan, the Shares shall be issued pursuant to the preceding sentence as soon as administratively practicable after the Administrator determines that Shares can again be issued in accordance with such Section.
(b) As set forth in Section 10.5 of the Plan, the Company shall have the authority and the right to deduct or withhold, or to require the Participant to remit to the Company, an amount sufficient to satisfy all applicable federal, state and local taxes required by law to be withheld with respect to any taxable event arising in connection with the Restricted Stock Units. The Company shall not be obligated to deliver any Shares to the Participant or the Participant’s legal representative unless and until the Participant or the Participant’s legal representative shall have paid or otherwise satisfied in full the amount of all federal, state and local taxes applicable to the taxable income of the Participant resulting from the grant or vesting of the Restricted Stock Units or the issuance of Shares.
2.11 Conditions to Delivery of Shares. The Shares deliverable hereunder may be either previously authorized but unissued Shares, treasury Shares or issued Shares which have then been reacquired by the Company. Such Shares shall be fully paid and nonassessable. The Company shall not be required to issue Shares deliverable under this Agreement prior to fulfillment of the conditions set forth in Section 10.7 of the Plan.
2.12 Rights as Stockholder. The holder of the PSUs shall not be, nor have any of the rights or privileges of, a stockholder of the Company, including, without limitation, voting rights and rights to dividends, in respect of the PSUs, the RSUs that may be issued following the Performance Period in connection with a Final Award and any Shares underlying the RSUs and deliverable under this Agreement unless and until such Shares shall have been issued by the Company and held of record by such holder (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Article IX of the Plan.
2.13 No Effect on Capital Structure. No award or right granted under this Agreement shall affect the right of the Company or any Subsidiary to reclassify, recapitalize or otherwise change its capital or debt structure or to merge, consolidate, convey any or all of its assets, dissolve, liquidate, windup, or otherwise reorganize.
2.14 Change In Control. If there is a Change in Control, the PSUs shall be converted into that number of RSUs equal to the Target Award, provided that, if the Committee reasonably determines that the Payout Percentage is greater than 100, the PSUs shall be converted into that number of RSUs equal to the Target Award, multiplied by the Payout Percentage. In each case, the RSUs will thereupon vest under the terms set forth in Section 2.7 of this Agreement and otherwise be treated in accordance with Section 9.3 of the Plan.
ARTICLE 3
OTHER PROVISIONS
3.1 Administration. The Administrator shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Administrator in good faith shall be final and binding upon the Participant, the Company and all other interested persons. No member of the Administrator or the Board shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan, this Agreement or the PSUs or RSUs.
3.2 PSUs/RSUs Not Transferable. The PSUs and RSUs shall be subject to the restrictions on transferability set forth in Section 10.1 of the Plan.
3.3 Tax Consultation. The Participant understands that the Participant may suffer adverse tax consequences in connection with the PSUs granted pursuant to this Agreement, the RSUs issued in connection with a Final Award (and the Shares issuable with respect thereto). The Participant represents that the Participant has consulted with any tax consultants the Participant deems advisable in connection with the PSUs, the RSUs and the issuance of Shares with respect thereto and that the Participant is not relying on the Company for any tax advice.
3.4 Binding Agreement. Subject to the limitation on the transferability of the PSUs and RSUs contained in this Agreement, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.
3.5 Adjustments Upon Specified Events. The Administrator may accelerate the vesting of the RSUs in such circumstances as it, in its sole discretion, may determine. The Participant acknowledges that the RSUs are subject to adjustment, modification and termination in certain events as provided in this Agreement and Article IX of the Plan.
3.6 Notices. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company at the Company’s principal office, and any notice to be given to the Participant shall be addressed to the Participant at the Participant’s last address reflected on the Company’s records. By a notice given pursuant to this Section 3.6, either party may hereafter designate a different address for notices to be given to that party. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service.
3.7 Participant’s Representations. If the Shares issuable hereunder have not been registered under the Securities Act or any applicable state laws on an effective registration statement at the time of such issuance, the Participant shall, if required by the Company, concurrently with such issuance, make such written representations as are deemed necessary or appropriate by the Company or its counsel.
3.8 Titles. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.
3.9 Governing Law. The laws of the State of Delaware shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws.
3.10 Conformity to Securities Laws. The Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act and any other Applicable Law. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the RSUs are granted, only in such a manner as to conform to Applicable Law. To the extent permitted by Applicable Law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such Applicable Law.
3.11 Amendment, Suspension and Termination. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator or the Board.
3.12 Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject
3.13 Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan or this Agreement, if the Participant is subject to Section 16 of the Exchange Act, then the Plan, the PSUs, the RSUs issued in connection with a Final Award and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by Applicable Law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.
3.14 Not a Contract of Service Relationship. Nothing in this Agreement or in the Plan shall confer upon Participant any right to continue to serve as an employee or other service provider of the Company or any of its Subsidiaries or interfere with or restrict in any way with the right of the Company or any of its Subsidiaries, which rights are hereby expressly reserved, to discharge or to terminate for any reason whatsoever, with or without cause, the services of the Participant at any time.
3.15 Entire Agreement. The Plan, the Grant Notice and this Agreement (including all Schedules thereto, if any) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and the Participant with respect to the subject matter hereof.
3.16 Section 409A. This Award is not intended to constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof, “Section 409A”). However, notwithstanding any other provision of the Plan, the Grant Notice or this Agreement, if at any time the Administrator determines that this Award (or any portion thereof) may be subject to Section 409A, the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the Plan, the Grant Notice or this Agreement, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Administrator determines are necessary or appropriate for this Award either to be exempt from the application of Section 409A or to comply with the requirements of Section 409A.
3.17 Limitation on Participant’s Rights. Participation in the Plan confers no rights or interests other than as provided in this Agreements. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. The Participant shall have only the rights of a general unsecured creditor of the Company and its Subsidiaries with respect to amounts credited and benefits payable, if any, with respect to the PSUs, and rights no greater than the right to receive the Common Stock as a general unsecured creditor with respect to RSUs, as and when payable under this Agreement.
* * * * *
Schedule 1
Calculation of Payout Percentage
EX-31.1
3
a20250331exhibit311.htm
EX-31.1
Document
CERTIFICATION OF PERIODIC REPORT
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, the undersigned, Patrick Goepel, certify, that:
1.I have reviewed this quarterly report on Form 10-Q of the Company (the “Report”);
2.Based on my knowledge, the Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this Report;
3.Based on my knowledge, the financial statements, and other financial information included in the Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in the Report;
4.The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and we have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within these entities, particularly during the period in which the Report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in the Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by the Report based on such evaluation; and
(d)Disclosed in the Report any change in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter (the quarter ended March 31, 2025) that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and
5.The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and to the Audit Committee of the Board of Directors:
(a)All significant deficiencies or material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.
|
|
|
|
|
|
|
|
|
Date: May 1, 2025 |
By: |
/s/ Patrick Goepel |
|
|
Patrick Goepel |
|
|
Chief Executive Officer |
EX-31.2
4
a20250331exhibit312.htm
EX-31.2
Document
CERTIFICATION OF PERIODIC REPORT
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, the undersigned, John Pence, certify, that:
1.I have reviewed this quarterly report on Form 10-Q of the Company (the “Report”);
2.Based on my knowledge, the Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this Report;
3.Based on my knowledge, the financial statements, and other financial information included in the Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in the Report;
4.The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and we have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within these entities, particularly during the period in which the Report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in the Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by the Report based on such evaluation; and
(d)Disclosed in the Report any change in the Company’s internal control over financial reporting that occurred during the Company’s most recent fiscal quarter (the quarter ended March 31, 2025) that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and
5.The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and to the Audit Committee of the Board of Directors:
(a)All significant deficiencies or material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.
|
|
|
|
|
|
|
|
|
Date: May 1, 2025 |
By: |
/s/ John Pence |
|
|
John Pence |
|
|
Chief Financial Officer and Principal Accounting Officer |
EX-32.1
5
a20250331exhibit321.htm
EX-32.1
Document
CERTIFICATION OF PERIODIC REPORT
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, the undersigned, Patrick Goepel, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The quarterly report on Form 10-Q of the Company for the period ended March 31, 2025 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended, and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
|
|
|
|
|
|
Date: May 1, 2025 |
By: |
/s/ Patrick Goepel |
|
|
Patrick Goepel |
|
|
Chief Executive Officer |
A signed original of this written statement required by Section 906 has been provided to Asure Software, Inc. and will be retained by Asure Software, Inc. and furnished to the Securities and Exchange Commission or its staff upon request. The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.
EX-32.2
6
a20250331exhibit322.htm
EX-32.2
Document
CERTIFICATION OF PERIODIC REPORT
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, the undersigned, John Pence, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The quarterly report on Form 10-Q of the Company for the period ended March 31, 2025 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 as amended, and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
|
|
|
|
|
|
|
Date: May 1, 2025 |
By: |
/s/ John Pence |
|
|
John Pence |
|
|
Chief Financial Officer and Principal Accounting Officer |
A signed original of this written statement required by Section 906 has been provided to Asure Software, Inc. and will be retained by Asure Software, Inc. and furnished to the Securities and Exchange Commission or its staff upon request. The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.